| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 08/05/2008 | CA2337098C Anthranilic acid derivatives |
| 08/05/2008 | CA2293358C Tricyclic sulfonamide inhibitors of farnesyl-protein transferase |
| 07/31/2008 | WO2008091085A1 Crystalline s-(-)-amlodipine orotate anhydrous and preparation method thereof |
| 07/31/2008 | WO2008068423A3 P<0}{0pyrrol derivatives, preparation and use of the same in therapy<0} |
| 07/31/2008 | WO2008057775A3 Heterocyclic amide compounds useful as kinase inhibitors |
| 07/31/2008 | WO2008046918A3 Addition reactions using transition metal catalysts in halogenated solvents |
| 07/31/2008 | WO2008042896A3 Tetra-substituted ndga derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use |
| 07/31/2008 | US20080182991 N- and o-substitued 4-[2-(diphenylmethoxy)-ethyl]-1-[(phenyl)methyl]piperidine analogs and methods of treating cns disorders therewith |
| 07/31/2008 | US20080182990 Process for the Preparation of Irinotecan Hydrochloride Trihydrate |
| 07/31/2008 | US20080182986 ring-fluorinated aromatics by a halogen exchange reaction (halex reaction) of a plurality of halogen substituents in one stage in the presence of (N,N-dimethylimidazolidino)tetramethylguanidinium chloride or bromide catalyst, using alkali, alkaline or ammonium fluoride |
| 07/31/2008 | US20080182881 TNF-alpha production inhibitors |
| 07/31/2008 | US20080182876 Histamine H3-Receptor Ligands and Their Therapeutic Application |
| 07/31/2008 | US20080182830 Agent for Treatment and Prevention of Endometriosis and Uterine Adenomyosis |
| 07/31/2008 | DE102007010815B3 New N-phenylsulfonyl-3-amidino-phenylalanine piperidide derivatives useful as antitumor agents |
| 07/30/2008 | EP1950211A1 Process for production of cinnamamide derivative |
| 07/30/2008 | EP1950201A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 07/30/2008 | EP1950196A1 Method for manufacturing ammonium hexafluorphosphates |
| 07/30/2008 | EP1948629A1 Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor |
| 07/30/2008 | EP1948607A2 Cyclopropyl amines as modulators of the histamine h3 receptor |
| 07/30/2008 | EP1948606A1 3, 5-disubstituted phenyl-piperidines as modulators of dopamine neurotransmission |
| 07/30/2008 | EP1948597A1 Derivatives for modulation of ion channels |
| 07/30/2008 | EP1685103B1 3-aminopyrrolidone derivatives |
| 07/30/2008 | EP1254124B1 Dipeptide nitrile cathepsin k inhibitors |
| 07/30/2008 | CN101233138A Pyrrolo[2,3-d]pyrimidine derivatives, their intermediates and synthesis |
| 07/30/2008 | CN101233109A N-(pyridin-4-yl)-2-phenylbutanamides as androgen receptor modulators |
| 07/30/2008 | CN101233108A Cyclic amine derivative having substituted alkyl group |
| 07/30/2008 | CN101233107A Novel piperidine derivatives as chemokine receptor modulators useful for the treatment of respiratory diseases |
| 07/30/2008 | CN101233106A Thiomorpholine compound and process for preparing the same |
| 07/30/2008 | CN101230035A Aspartic acid amlodipine series salt as well as preparation method, composition, preparation and tablets thereof |
| 07/30/2008 | CN101230034A Nitrogen hetero-cycle compounds for use in the treatment of 5-hydroxide tryptamines related diseases |
| 07/30/2008 | CN100406449C CDC25 phosphatase inhibitors |
| 07/30/2008 | CN100406441C Cyclic amine compounds |
| 07/30/2008 | CN100406435C 1- (alkylaminoalkyl-pyrolidin-/piperidinyl) -2, 2-diphenylacetamide derivatives as muscarinic receptor antagonists |
| 07/29/2008 | US7405307 N-(p-(2-alpha-carboxybenzylamino)ethylamino)phenyl)p-(p-trifluoromethylphenyl)benzamide; antiobesity and anti-type II diabetic agents |
| 07/29/2008 | US7405305 Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitors |
| 07/29/2008 | US7405298 Process for making risperidone and intermediates therefor |
| 07/29/2008 | US7405229 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders |
| 07/29/2008 | CA2323315C Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds |
| 07/29/2008 | CA2218096C New arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds |
| 07/29/2008 | CA2175767C Adhesion receptor antagonists |
| 07/29/2008 | CA2168192C 4-aminobenzoylguanidine derivatives |
| 07/24/2008 | WO2008087654A2 PIPERIDINES AS INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 |
| 07/24/2008 | WO2008087421A2 Male contraceptive |
| 07/24/2008 | WO2008053352A3 Phenylpropionamide compounds and the use thereof |
| 07/24/2008 | WO2008016666A3 Certain chemical entities, compositions, and methods |
| 07/24/2008 | WO2007035425A3 Cyclopropyl amines as modulators of the histamine h3 receptor |
| 07/24/2008 | US20080177070 Synthesis of piperazines, piperidines and related compounds |
| 07/24/2008 | US20080176903 Novel Compounds with Analgesic Effect |
| 07/24/2008 | US20080176902 N-{2-[((2S)-3-{[1-(4-chlorobenzyl)piperidin-4-yl]amino}-2-hydroxy-2-methylpropyl)oxy]-4-hydroxyphenyl}acetamide hemifumarate; chemokine receptor 1 modulation; chronic obstructive pulmonary disease, asthma; chemical stability; easy to handle; inhalant formulations |
| 07/24/2008 | US20080176898 Leukotriene antagonists; cardiovascular disorders like unstable angina pectoris or myocardial infarction; Methyl 1-{[5-(ethoxycarbonyl)-2-(3-{4-[(4-isopropoxybenzyl)oxy]phenyl}propoxy)phenyl]-acetyl}piperidine-4-carboxylate |
| 07/24/2008 | US20080176838 e.g. [3-[(Cyclopropanecarbonyl-amino)-methyl]-pyrrolidin-1-yl}-(2-fluoro-benzyl)-propyl]-carbamic acid tert-butyl ester; dipeptidyl-peptidase inhibitor; antidiabetic, hypoglycemic agent; metabolic disorders, obesity, non-insulin dependent diabetes; |
| 07/24/2008 | US20080176827 e.g. ethyl 6-(3-{2-[(benzylsulfonyl)amino]-2-oxoethyl}pyrrolidin-1-yl)-5-cyano-2-methylnicotinate; P2Y12 (G-protein coupled receptor) antagonist and anti-trombotic agent; high potency and selectivity; cardiovascular disorders, platelet aggregation disorder, acute thrombotic occlusion |
| 07/23/2008 | EP1947098A1 Cyclic amine compounds and pest control agent |
| 07/23/2008 | EP1947086A1 Benzene derivative or salt thereof |
| 07/23/2008 | EP1945614A1 Process for preparation of chiral amlodipine gentisate |
| 07/23/2008 | EP1945613A1 Novel 1 -benzyl-4-piperidinamines that are useful in the treatment of copd and asthma |
| 07/23/2008 | EP1945609A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 07/23/2008 | EP1945606A1 Alkylcarbamoyl naphthalenyloxy- octenoylhydroxyamide derivatives having inhibitory activity against histone deacetylase and preparation thereof |
| 07/23/2008 | EP1685108B1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease |
| 07/23/2008 | EP1671949B1 Substituted Pyridinylamines |
| 07/23/2008 | EP1615909B1 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases |
| 07/23/2008 | EP1532110B1 Industrial process for the synthesis of isobutyl methyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridine dicarboxylate (nisoldipine) |
| 07/23/2008 | CN101228127A Novel piperidine derivative |
| 07/23/2008 | CN101227901A Anti-inflammatory agents |
| 07/22/2008 | US7402698 1-[2-(benzylamino)-1-(3,4-dichlorophenyl)ethyl]cyclobutanol hydrochloride; norepinephrine reuptake inhibitor; antidepressant, analgesic; vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, sleep disorder, hormone replacement syndrome |
| 07/22/2008 | US7402696 exert an ACC activity-inhibiting effect that is effective in the treatment of obesity, hyperlipemia, fatty liver, hyperglycemia, impaired glucose tolerance, diabetes, diabetic complications (diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, and diabetic macroangiopathy, hyperten |
| 07/22/2008 | US7402675 Process for the synthesis of amine ethers from secondary amino oxides |
| 07/22/2008 | US7402670 Synthesis by chiral diamine-mediated asymmetric alkylation |
| 07/22/2008 | US7402639 Narrow moleculae weight distribution; addition piolymers; process control |
| 07/22/2008 | US7402596 e.g. 2-Adamantan-1-yl-N-(2-isobutyl-1-oxo-1,2-dihydro-isoquinolin-5-yl)-ace tamide; antiinflammatory and analgesic agent; rheumatoid arthritis, osteoarthritis, Parkinson's disease, uveitis, asthma, cardiovascular conditions, myocardial infarction |
| 07/22/2008 | CA2481246C Compounds that modulate ppar activity and methods for their preparation |
| 07/22/2008 | CA2289017C The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer |
| 07/22/2008 | CA2278223C 1,4-dihydropyridin derivatives and their use in therapy |
| 07/17/2008 | WO2008084750A1 Piperidine compound, and method for producing intermediate thereof |
| 07/17/2008 | WO2008045564A8 Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor |
| 07/17/2008 | WO2008045192A3 Alternate process for remifentanil preparation |
| 07/17/2008 | US20080171881 Method for Producing Organic Compound and Method for Decomposing Compound Having Dicarboximide Skeleton |
| 07/17/2008 | US20080171767 N-substituted-2-alkylthio-2-(substituted aryloxy and heteroaryloxy)alkylamides and their sulphinyl and sulphonyl derivatives such as 2-(3,5-dichlorophenoxy)-2-methylthio-N-2-methylprop-2-yl acetamide; fungal infections of plants |
| 07/17/2008 | US20080171741 e.g. 5-(4-Chlorophenyl)-N-(5-(cyclopropylcarbamoyl)-2-methylphenyl)furan-2-carboxamide; p38 alpha and beta kinase inhibitor; antiinflammatory agent; asthma, inflammatory bowel disease, osteoporosis, psoriasis, graft vs. host rejection, atherosclerosis, multiple myeloma, pain, myocardial ischemia |
| 07/17/2008 | US20080171692 Substituted amides |
| 07/17/2008 | DE19618586B4 Monoazo-Dispersionsfarbstoffe Monoazo disperse dyes |
| 07/17/2008 | CA2673856A1 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
| 07/16/2008 | EP1943240A2 Chemical process |
| 07/16/2008 | EP1943236A2 Process for the synthesis of amine ethers |
| 07/16/2008 | EP1943217A1 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses |
| 07/16/2008 | EP1943216A1 Prolinamide derivatives as sodium channel modulators |
| 07/16/2008 | EP1942893A2 Piperidine glycine transporter inhibitors |
| 07/16/2008 | EP1942888A2 Certain chemical entities, compositions, and methods |
| 07/16/2008 | EP1942733A2 Radiolabeled glycine transporter inhibitors |
| 07/16/2008 | EP1830840B1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/16/2008 | EP1506205B1 Novel azacyclic ethynyl derivatives |
| 07/16/2008 | EP1286966B1 4-aminopiperidine derivatives and their use as medicine |
| 07/16/2008 | CN101223140A Piperidine derivatives useful in the diagnostic and therapeutic treatment of diseases depending on renin activity |
| 07/16/2008 | CN101219142A Method for preparing small-molecule antineoplastic medicament with specificity for CYP2J2 and medical use thereof |
| 07/16/2008 | CN100402612C Ink-jet ink and recording material |
| 07/16/2008 | CN100402084C Method for detection or quantitative determination of metabolite of fentanyl or metabolite of fentanyl analogues and kit |
| 07/15/2008 | US7399867 1-(2-{4-[2-(4-Methanesulfonyl-phenyl)-6-methoxy-3,4-dihydro-naphthalen-1-yloxy]-phenoxy}-ethyl)-piperidine for therapy of endometriosis and/or uterine leiomyoma/leiomyomata |
| 07/15/2008 | US7399866 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents |
| 07/15/2008 | US7399775 β-amyloid protein production/secretion inhibitor |
| 07/15/2008 | US7399774 6-substituted nicotinamide derivatives as opioid receptor antagonists |